The development of cancer cannot always be prevented by a healthy lifestyle. But some cancers can be detected early and treated well in the early stages. Regular check-ups are therefore essential.
Cancer affects the lives of more and more people. Thanks to the latest advances in medical science, today most cases can be successfully cured if the disease is diagnosed at an early stage. According to WHO statistics, more than 40% of cancer cases can be prevented.
Vienna has earned an international reputation in cancer research and ranks among top countries worldwide. At the Medical University of Vienna, research is carried out at a very high, internationally recognized level, with the aim of quickly making research results available for the continuous development of new treatment concepts.
The treatment of lung cancer has changed dramatically. Due to availability of completely new and constantly developing forms of conservative treatment, patients with advanced diseases, who until a few years ago had to be considered hopeless, have realistic chances of cure.
A cancer diagnosis often causes shock in patients. But also doubts - is it really cancer? Is surgery urgently needed? Does it have to be chemotherapy or is there an alternative? In order for the patient to be able to make an informed decision about his treatment, it is advisable to obtain a second opinion from a team of experts.
The latest diagnostic advances also allow to detect precancerous conditions or cancer at a very early stage and to start treatment immediately. Many oncological diseases do not show symptoms for a long time. A person may lead a normal life without any complaints or any cancer symptoms. At this stage, almost any disease can be treated successfully, therefore, it is vital to undergo regular examinations and identify indications of potential diseases.
Austria is one of the leading countries in the world in cancer research. This is primarily due to internationally renowned research projects carried out by the Medical University of Vienna. Experts confirm that even patients with major tumors, which cannot be treated with standard therapies, can benefit from new molecular biologic treatment approaches.
This website uses necessary cookies to ensure the functionality and security of the website. Provided that you have given your consent by ticking the respective checkbox, we also use non-essential cookies and similar technologies for statistical and analysis purposes. These help us to evaluate the online behavior of our visitors and thus to continuously improve our information offering. If you agree by ticking the respective checkbox, we also include content on this website that is provided via other websites, such as the PremiQaMed Group’s YouTube channel. In the process, we also use providers in third countries that are without an adequate level of data protection, in particular the United States. As a result, there is a possibility that the transferred data could be processed by local authorities and that you will not have an effective legal recourse against this. By checking the respective box or by clicking on “Agree to all”, you expressly agree that we or the providers (also located in third countries, in particular the United States) may use the aforementioned technologies to the full extent. For further information and the possibility to edit and change your settings at any time, please see our Data Protection Statement.
Protects against cross-site request forgery attacks.
Saves the display status of the notification popup.
Storage duration: Variable
Technical name: overlay
Saves the display status of the notification bar.
Storage duration: 1 year
Technical name: promotion
For showing or hiding the Share bar.
Storage duration: 1 year
Technical name: share_bar
Provider:
Tag management system from Google Inc.
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “Google Tag Manager” of our Data Protection Statement.
Provider:
Web analysis service from Google Inc.
Storage duration: 2 years, 2 years, session (current browsing session), 1 day
Technical name: _ga,_ga_L3MEHLCG3J,_gid,_gat
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “Google Analytics” of our Data Protection Statement.
Provider:
Analysis tool from Meta Platforms Ireland Ltd.
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “Google Tag Manager” of our Data Protection Statement.
Provider:
Video service from YouTube LLC
Storage duration: 2 years, 6 months, session (current browsing session)
Technical name: CONSENT,VISITOR_INFO1_LIVE,YSC
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “YouTube” of our Data Protection Statement.
Provider:
Map service from Google Inc.
Additional information as well as a notice about data transmission to third countries, in particular the United States, can be found in the section “Google Maps” of our Data Protection Statement.
1 possible transmission of data to the United States
